To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 29, 2025

Primary Completion Date

April 16, 2025

Study Completion Date

April 18, 2025

Conditions

Hypercholesterolemia

Interventions

DRUG

Test Drug

AJU-C711

DRUG

Reference Drug

C711R

Trial Locations (1)

Bumin Hospital, Seoul, Republic of South Korea, Seoul

All Listed Sponsors

lead

AJU Pharm Co., Ltd.

INDUSTRY

NCT06931327 - To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults | Biotech Hunter | Biotech Hunter